Incorporating individually defined brain health priorities in clinical trial outcomes: the electronic Person‐Specific Outcome Measure approach in the United States

Abstract INTRODUCTION While a limited number of disease‐modifying treatments for Alzheimer's disease (AD) have been approved in the United States, there is caution in adopting these treatments in clinical use. The electronic Person‐Specific Outcome Measure (ePSOM) tool was recently developed to esta...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Stina Saunders, Ali Jannati, Shane Sheehan, Claudio Toro‐Serey, Sean Tobyne, Killian McManus, David Bates, John Showalter, Álvaro Pascual‐Leone
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-04-01
Edice:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Témata:	Alzheimer's disease clinical meaningfulness mild cognitive impairment outcome measures patient‐reported outcomes
On-line přístup:	https://doi.org/10.1002/trc2.70088
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!